Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study
Experimental and Clinical Transplantation · 2019-12 · 17 (6) · 739-748
DOI: 10.6002/ect.2017.0225 ↗At a glance
Vergleichsstudie in Experimental and Clinical Transplantation, 2019-12. Written by Jonathan Demeter and 5 co-authors. Institution: From the Department of Urology, University of Toledo, College of Medicine and Life Sciences, Toledo, Ohio, USA. Major MEDLINE topics: Health Status Disparities, Kidney Transplantation. Cited 2 times so far (Crossref); 40 references.
Abstract (original language)
Povzetek ni na voljo.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- From the Department of Urology, University of Toledo, College of Medicine and Life Sciences, Toledo, Ohio, USA.
Cite
APA
Demeter, J., Buck, B., Zimmerman, A., Mitro, G., Rees, M., & Ortiz, J. (2019). Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study. Experimental and Clinical Transplantation, 17(6), 739-748. https://doi.org/10.6002/ect.2017.0225
Vancouver
Demeter J, Buck B, Zimmerman A, Mitro G, Rees M, Ortiz J. Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study. Experimental and Clinical Transplantation. 2019;17(6):739-748. doi:10.6002/ect.2017.0225
BibTeX
@article{Demeter2019,
author = {Demeter, Jonathan and Buck, Bradley and Zimmerman, Allison and Mitro, Graham and Rees, Michael and Ortiz, Jorge},
title = {Alemtuzumab Induction Reduces Early Rejection in Female Renal Allograft Recipients: A Single Center Study},
journal = {Experimental and Clinical Transplantation},
year = {2019},
volume = {17},
number = {6},
pages = {739--748},
doi = {10.6002/ect.2017.0225}
}
EUVIMED